REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
The purpose of this study is to see whether a supportive intervention (REVITALIZE) reduces fatigue and its impact on daily life and activities for participants with ovarian cancer taking PARP inhibitors. The name of the study groups in this research study are: 1. REVITALIZE 2. Educational Materials
Adult patients (age ≥ 18 years) with ovarian, fallopian tube, or primary periton... [+5]
Untreated clinical condition or comorbid condition that pre-dates PARP inhibitor... [+3]